Pseudoephedrine Tide Turns: Nonprescription Sales Return In Mississippi, Oregon Mulls Change
Mississippi repeals prescription requirement for all pseudoephedrine- and ephedrine-containing drugs while also requiring retailer participation in industry-funded technology for tracking drug sales. Oregon, the only other state with PSE Rx law, is considering repealing it.
You may also be interested in...
Pseudoephedrine Safety Review Initiated In EU Over Link To Neurological Problems
Reports of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome have triggered a European Union-wide safety review of pseudoephedrine.
Manufacturers Consider Design Changes For OTC Propylhexedrine Nasal Decongestant Inhalers
"Manufacturers are already working on possible solutions to address the concerns and will work with the Agency to implement any appropriate measures,” says CHPA senior VP Barbara Kochanowski.
Propylhexedrine Abuse Prompts US FDA To Suggest OTC Nasal Inhaler Modifications, Smaller Size
FDA published warning against abuse of propylhexedrine, but study published in October 2020 questioned why sales of products with the ingredient aren’t limited like sales of pseudoephedrine-containing OTCs under a federal law.